Effect of Morus Nigra Mouthwash on Gingivitis Treatment
Evaluation of the Efficacy of Morus Nigra Mouthwash as an Adjunct to Scaling and Root Planing in the Treatment of Gingivitis: A Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this study is to evaluate the clinical, microbiological, and biochemical effects of Morus nigra (black mulberry) mouthwash when used as an adjunct to non-surgical periodontal treatment (scaling and root planing - SRP) in patients with generalized gingivitis. Participants will be randomly assigned to two groups: one receiving SRP only, and the other receiving SRP plus Morus nigra mouthwash twice daily for 14 days. Clinical parameters, cytokine levels in gingival crevicular fluid (TNF-alpha, IL-1beta, IL-10), and subgingival bacterial load will be assessed at baseline, 1 month, and 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2026
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2026
ExpectedApril 13, 2026
April 1, 2026
1 month
March 24, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Gingival Index (GI)
Gingival inflammation will be assessed using the Loe and Silness Gingival Index. Higher scores indicate more severe inflammation.
Baseline, 1 month, and 3 months.
Secondary Outcomes (2)
Cytokine levels in Gingival Crevicular Fluid (GCF)
Baseline, 1 month, and 3 months
Subgingival Bacterial Load
Baseline, 1 month, and 3 months
Study Arms (2)
Control Group
ACTIVE COMPARATORPatients in this group receive scaling and root planing (SRP) only.
Test Group
EXPERIMENTALPatients in this group receive scaling and root planing (SRP) followed by the use of Morus nigra mouthwash twice daily for 14 days
Interventions
Mechanical removal of dental plaque and calculus from the tooth surfaces
Morus nigra extract based mouthwash, used 2 times a day for 14 days
Eligibility Criteria
You may qualify if:
- Diagnosis of generalized gingivitis (Gingival Index \> 1).
- Presence of at least 20 natural teeth.
- Systemically healthy individuals.
- Ability to provide informed consent.
You may not qualify if:
- Smoking or use of tobacco products.
- Presence of periodontitis (no clinical attachment loss).
- Use of antibiotics or anti-inflammatory drugs in the last 6 months.
- Pregnancy or lactation.
- History of allergy to Morus nigra or mouthwash components.
- Systemic diseases (Diabetes, cardiovascular diseases, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inonu Universitylead
Study Sites (1)
Inonu University Faculty of Dentistry
Battalgazi, Malatya, 44300, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 24, 2026
First Posted
March 30, 2026
Study Start
January 15, 2026
Primary Completion
February 15, 2026
Study Completion (Estimated)
July 15, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Starting 6 months after publication and for up to 5 years
- Access Criteria
- Data will be available to researchers who provide a methodologically sound proposal to achieve aims in the approved proposal
All collected individual participant data after de-identification (clinical indices, cytokine levels, and microbiological data)